Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Neutralization
Human
IgG1, kappa
5E1#
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
FCM, Neutralization, SPR
Human
IgG1, kappa
2E6#
Human coronavirus HKU1 (HCoV-HKU1), Human coronavirus OC43 (HCoV-OC43), Middle East respiratory syndrome-related coronavirus (MERS-CoV), Severe acute respiratory syndrome coronavirus (SARS-CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Neutralization
Human
IgG1, kappa
S2P6
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Severe acute respiratory syndrome coronavirus (SARS-CoV)
ELISA, Neutralization
Human
IgG1, kappa
S309
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
Neutralization
Human
IgG1, kappa
S41
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Neutralization, IF
Human
IgG1, kappa
D12
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Neutralization
Human
IgG1, kappa
4C2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
VIR-7229
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
3A1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
BA7535